PT3694557T - Excipientes modificadores de libertação à base de amido e composições farmacêuticas derivadas dos mesmos - Google Patents
Excipientes modificadores de libertação à base de amido e composições farmacêuticas derivadas dos mesmosInfo
- Publication number
- PT3694557T PT3694557T PT188671986T PT18867198T PT3694557T PT 3694557 T PT3694557 T PT 3694557T PT 188671986 T PT188671986 T PT 188671986T PT 18867198 T PT18867198 T PT 18867198T PT 3694557 T PT3694557 T PT 3694557T
- Authority
- PT
- Portugal
- Prior art keywords
- starch
- pharmaceutical compositions
- derived therefrom
- based release
- compositions derived
- Prior art date
Links
- 229920002472 Starch Polymers 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000546 pharmaceutical excipient Substances 0.000 title 1
- 235000019698 starch Nutrition 0.000 title 1
- 239000008107 starch Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762572037P | 2017-10-13 | 2017-10-13 | |
| GB1716965.7A GB2567493B (en) | 2017-10-13 | 2017-10-16 | Starch-based release modifying excipients and pharmaceutical compositions derived therefrom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3694557T true PT3694557T (pt) | 2022-05-23 |
Family
ID=60419086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT188671986T PT3694557T (pt) | 2017-10-13 | 2018-10-11 | Excipientes modificadores de libertação à base de amido e composições farmacêuticas derivadas dos mesmos |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US11058773B2 (pt) |
| GB (1) | GB2567493B (pt) |
| PT (1) | PT3694557T (pt) |
| WO (1) | WO2019071348A1 (pt) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807575A (en) | 1997-02-14 | 1998-09-15 | Rougier Inc. | Manufacture of cross-linked amylose useful as a excipient for control release of active compounds |
| US6284273B1 (en) * | 1998-02-24 | 2001-09-04 | Vincent Lenaerts | Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds |
| FR2779439B1 (fr) | 1998-06-08 | 2000-08-25 | Roquette Freres | Composition diluante et desintegrante, son procede d'obtention et son utilisation |
| US6607748B1 (en) * | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| WO2004064544A1 (en) * | 2003-01-22 | 2004-08-05 | Durafizz, Llc | Microencapsulation for sustained delivery of carbon dioxide |
| JP5269595B2 (ja) | 2005-09-09 | 2013-08-21 | アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー | １日１回投与用トラゾドン組成物 |
| RU2440104C2 (ru) * | 2006-07-27 | 2012-01-20 | Юнивёсити Оф Сандерлэнд | Композиция покрытия, содержащая крахмал |
| ES2541809T3 (es) * | 2007-10-16 | 2015-07-24 | Paladin Labs Inc. | Composición bicapa para la liberación sostenida de acetaminofeno y tramadol |
| EP2219612A4 (en) * | 2007-12-17 | 2013-10-30 | Paladin Labs Inc | CONTROLLED RELEASE FORMULATION AVOIDING IMPROPER USES |
| WO2010028489A1 (en) | 2008-09-15 | 2010-03-18 | Labopharm Inc. | Starch-based microparticles for the release of agents disposed therein |
| JP5713911B2 (ja) | 2008-10-27 | 2015-05-07 | アルザ・コーポレーシヨン | 長期放出型経口アセトアミノフェン／トラマドール投与形態 |
-
2017
- 2017-10-16 GB GB1716965.7A patent/GB2567493B/en active Active
-
2018
- 2018-10-11 US US16/477,028 patent/US11058773B2/en active Active
- 2018-10-11 WO PCT/CA2018/051279 patent/WO2019071348A1/en unknown
- 2018-10-11 PT PT188671986T patent/PT3694557T/pt unknown
-
2021
- 2021-06-11 US US17/345,462 patent/US11529419B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11058773B2 (en) | 2021-07-13 |
| GB2567493A (en) | 2019-04-17 |
| US20200297857A1 (en) | 2020-09-24 |
| GB2567493B (en) | 2019-12-18 |
| US11529419B2 (en) | 2022-12-20 |
| WO2019071348A1 (en) | 2019-04-18 |
| GB201716965D0 (en) | 2017-11-29 |
| US20210299259A1 (en) | 2021-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1259145A1 (zh) | 3-脫氧衍生物及其藥物組合物 | |
| IL271275A (en) | Preparations containing coronas and their uses | |
| ZA201901032B (en) | Immunogenic/therapeutic glycan compositions and uses thereof | |
| IL269061A (en) | A pharmaceutical preparation containing Selexifag | |
| IL271759A (en) | Pharmaceutical preparations that include anthraxtinib | |
| GB201705303D0 (en) | Pharmaceutical compositions | |
| EP3313187A4 (en) | FORMULATION WITH DELAYED RELEASE AND TABLETS MANUFACTURED THEREFROM | |
| IL270273B1 (en) | Highly charged drug formulations with enhanced sustained release | |
| EP3773654C0 (en) | POLYPHARMACEUTICAL DRUG COMPOSITIONS AND ASSOCIATED METHODS | |
| PL3638278T3 (pl) | Kompozycje neuroprotekcyjne i ich zastosowanie | |
| HK1245113A1 (zh) | 藥物組合物及其用途 | |
| GB201705304D0 (en) | Pharmaceutical compositions | |
| EP3373907A4 (en) | EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE | |
| ZA202000959B (en) | Adamantylmethylamine derivative and use thereof as pharmaceutical | |
| IL271908A (en) | Over-compressed pharmaceutical preparations | |
| PT3694557T (pt) | Excipientes modificadores de libertação à base de amido e composições farmacêuticas derivadas dos mesmos | |
| EP3691645A4 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING GELLING AGENT COMPOSITIONS | |
| PL3638211T3 (pl) | Kompozycje farmaceutyczne o opóźnionym, przedłużonym uwalnianiu | |
| EP3694557A4 (en) | STARCH-BASED RELEASE MODIFIER EXCIPIENTS AND PHARMACEUTICAL COMPOSITIONS DERIVED THEREOF | |
| GB201713920D0 (en) | Pharmaceutical compositions and uses thereof | |
| ZA201903341B (en) | Pharmaceutical compositions and uses thereof | |
| SG11202004167XA (en) | Immunogenic compositions and uses therefor | |
| EP3592350A4 (en) | PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
| EP3576721A4 (en) | COMPOSITION WITH IMMEDIATE RELEASE AND DELAYED RELEASE OF CAPECITABIN | |
| GB201716745D0 (en) | New formulations and uses thereof |